Literature DB >> 19221507

Viral subversion of immunogenic cell death.

Oliver Kepp1, Laura Senovilla, Lorenzo Galluzzi, Theocharis Panaretakis, Antoine Tesniere, Frederic Schlemmer, Frank Madeo, Laurence Zitvogel, Guido Kroemer.   

Abstract

While physiological cell death is non-immunogenic, pathogen induced cell death can be immunogenic and hence stimulate an immune response against antigens that derive from dying cells and are presented by dendritic cells (DCs). The obligate immunogenic "eat-me" signal generated by dying cells consists in the exposure of calreticulin (CRT) at the cell surface. This particular "eat-me" signal, which facilitates engulfment by DCs, can only be found on cells that succumb to immunogenic apoptosis, while it is not present on cells dying in an immunologically silent fashion. CRT normally resides in the lumen of the endoplasmic reticulum (ER), yet can translocate to the plasma membrane surface through a complex pathway that involves elements of the ER stress response (e.g., the eIF2alpha-phosphorylating kinase PERK), the apoptotic machinery (e.g., caspase-8 and its substrate BAP31, Bax, Bak), the anterograde transport from the ER to the Golgi apparatus, and SNARE-dependent exocytosis. A large panoply of viruses encodes proteins that inhibit eIF2alpha kinases, catalyze the dephosphorylation of eIF2alpha, bind to caspase-8, Bap31, Bax or Bak, or perturb exocytosis. We therefore postulate that obligate intracellular pathogens have developed a variety of strategies to subvert CRT exposure, thereby avoiding immunogenic cell death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221507     DOI: 10.4161/cc.8.6.7939

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  31 in total

1.  Healing after death: antitumor immunity induced by oncolytic adenoviral therapy.

Authors:  Hong Jiang; Juan Fueyo
Journal:  Oncoimmunology       Date:  2014-07-03       Impact factor: 8.110

Review 2.  Immunogenic cell death in cancer and infectious disease.

Authors:  Lorenzo Galluzzi; Aitziber Buqué; Oliver Kepp; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2016-10-17       Impact factor: 53.106

3.  Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.

Authors:  Heng Yang; Yuting Ma; Guo Chen; Heng Zhou; Takahiro Yamazaki; Christophe Klein; Federico Pietrocola; Erika Vacchelli; Sylvie Souquere; Allan Sauvat; Laurence Zitvogel; Oliver Kepp; Guido Kroemer
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

4.  A physical interaction network of dengue virus and human proteins.

Authors:  Sudip Khadka; Abbey D Vangeloff; Chaoying Zhang; Prasad Siddavatam; Nicholas S Heaton; Ling Wang; Ranjan Sengupta; Sudhir Sahasrabudhe; Glenn Randall; Michael Gribskov; Richard J Kuhn; Rushika Perera; Douglas J LaCount
Journal:  Mol Cell Proteomics       Date:  2011-09-12       Impact factor: 5.911

Review 5.  Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.

Authors:  H Inoue; K Tani
Journal:  Cell Death Differ       Date:  2013-07-05       Impact factor: 15.828

6.  Attenuation of Equine Lentivirus Alters Mitochondrial Protein Expression Profile from Inflammation to Apoptosis.

Authors:  Cheng Du; Yingyi Duan; Xue-Feng Wang; Yuezhi Lin; Lei Na; Xinhui Wang; Kewei Chen; Xiaojun Wang
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

Review 7.  Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategies.

Authors:  Samuel T Workenhe; Karen L Mossman
Journal:  Mol Ther       Date:  2013-10-19       Impact factor: 11.454

8.  Using gene expression profiles from peripheral blood to identify asymptomatic responses to acute respiratory viral infections.

Authors:  Alexander Statnikov; Nikita I Lytkin; Lauren McVoy; Jörn-Hendrik Weitkamp; Constantin F Aliferis
Journal:  BMC Res Notes       Date:  2010-10-20

9.  Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.

Authors:  Assia L Angelova; Svitlana P Grekova; Anette Heller; Olga Kuhlmann; Esther Soyka; Thomas Giese; Marc Aprahamian; Gaétan Bour; Sven Rüffer; Celina Cziepluch; Laurent Daeffler; Jean Rommelaere; Jens Werner; Zahari Raykov; Nathalia A Giese
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

Review 10.  Calreticulin: non-endoplasmic reticulum functions in physiology and disease.

Authors:  Leslie I Gold; Paul Eggleton; Mariya T Sweetwyne; Lauren B Van Duyn; Matthew R Greives; Sara-Megumi Naylor; Marek Michalak; Joanne E Murphy-Ullrich
Journal:  FASEB J       Date:  2009-11-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.